Cell Cryopreservation Market, by Product Type (Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others), by Application (Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others), by End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : Aug 2019 |
  • Pages : 192 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Cell Cryopreservation Market – Insights

Cryopreservation is a process of maintaining biological samples in a form of suspended state at cryogenic temperature for considerable period and is used to preserve the fine structure of cells. Through this process, samples of cells, tissues, and organelles are cooled at very low temperatures (less than -2130 degree F), for preservation. Cryopreservation is primarily used in the preservation of oocytes and embryos with in-vitro fertilization (IVF) cycle, prior to chemotherapy for women diagnosed with breast cancer, in order to preserve their reproductive capacity.

The global cell cryopreservation market size was valued at US$ 4,027.9 million in 2018, and is expected to exhibit a CAGR of 22.5% over the forecast period (2018–2026).

Figure 1. Global Cell Cryopreservation Market Value (US$ Mn), by Region, 2018

Cell Cryopreservation  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing government initiatives for preservation of stem cells is expected to augment the market growth

Government organizations’ initiatives for preservation of stem cells is a factor boosting the market growth. For instance, NCBP is the first and largest cord bank in the world, which recorded a collection of over 60,000 cord blood units, till 2016. NCBP has provided cord blood units for transplantation to over 4,900 recipients, throughout the world. Moreover, in 2011, Canada’s Ministry of Health, initiated Canada’s first national, publicly funded umbilical cord blood bank, which aims to provide donations for the allogeneic hematopoietic stem cell transplant.

Increasing launch of novel cryopreservation systems and approval of cryopreserved cells by regulatory authorities is also expected to bolster the market growth. For instance, in 2015, AMS Biotechnology Limited launched its new Stem-Cellbanker, a GMP grade cell cryopreservation media. Stem-Cellbanker is a freezing solution that is used for preservation of stem cells, induced pluripotent stem (iPS) cells, and other cells.

However, the adoption and development of alternative methods is expected to hinder the market growth. For instance, in May 2019, researchers at the University of Japan developed a technique to cryopreserve animal cells without using cryoprotectant agent. The researchers plan to apply this technique to a wide range of cells, specially cells sensitive to cryopreservation procedure.

Figure 2. Global Cell Cryopreservation Market Share (%), by Application, 2018 and 2026

Cell Cryopreservation  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing R&D expenditure by pharmaceutical and biotechnology companies in North America is expected to bolster the market growth

North America holds dominant position in the global cell cryopreservation market, owing to increasing expenditure on research and development activities by pharmaceutical and other companies. For instance, in 2013, Amgen Foundation launched an international program named Amgen Biotech Experience. The foundation also collaborated with non-profit organizations such as Education Development Center, Inc. (EDC) and provided grants amounting to US$ 30 Mn to local, regional, and international nonprofit organizations to provide technical assistance in biotechnology research.

Increasing focus of manufacturers on developing novel products for preserving various cells for research and use in medical settings is a major factor propelling the market growth. For instance, in 2018, Vanessa Research Inc., a startup company, launched a compact device aimed at batch cryopreservation, which allows freezing of multiple tissue samples, simultaneously.

Moreover, in January 2015, the precision medicine initiative proposed by the U.S. Government led to the creation of a new biobank that contains medical records and genetic information. The biobank is used for research of new disease-gene associations and for medical care. Therefore, increasing launch of biobanks is expected to lead to high demand for cell cryopreservation services, thereby aiding in the market growth in the region.   

Key Players

Major players operating in the global cell cryopreservation market include, General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Miltenyi Biotec GmbH, BioLifeSolutions Inc., HiMedia Laboratories Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., and Planer PLC.

The process of stabilizing biological materials at cryogenic temperatures (below -1500 degree C) is called cryopreservation. Cryopreservation is used for the preservation of microorganisms, tissue cells, established cell-lines, small multicellular organisms, and complex cellular structures such as embryos, nucleic acid, and proteins. Cryopreservation procedures use liquid nitrogen, liquid helium, argon, and oxygen as cryogenic elements. Various types of samples with varying sensitivity require different types of cryopreservation equipment such as cryopreservation freezers, liquid nitrogen vessels, cryogenic vaporizers, cryogenic incubators, liquid tracking equipment, and cell freezing container.

Market Dynamics

Increasing product launches by market players is a major factor driving the global cell cryopreservation market growth. For instance, in 2017, Irvine Scientific, a manufacturer of cell culture media, introduced Arctic Sperm Cryopreservation Medium to improve the post-thaw performance of frozen sperm samples and reduce the cost of sperm cryopreservation.

Furthermore, decrease in fertility rate is expected to drive the market growth.  According to the Journal of Human Reproductive Sciences, 2015, around 40-80% of females face possible infertility as a result of their cancer treatments that is, chemotherapy, radiation, and surgery.

Key features of the study:

  • This report provides in-depth analysis of the global cell cryopreservation market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global cell cryopreservation market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Miltenyi Biotec GmbH, BioLifeSolutions Inc., HiMedia Laboratories Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., and Planer PLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation:

  • Global Cell Cryopreservation Market, By Product Type:
    • Cryoprotectant Agents
      • Glycerol
      • Dimethyl Sulfoxide (DMSO)
      • Others
    • Equipment
      • Incubators
      • Liquid Nitrogen Supply Tanks
      • Freezers
      • Others
  • Global Cell Cryopreservation Market, By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
  • Global Cell Cryopreservation Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
  • Global Cell Cryopreservation Market, By Region:
    • North America
      • By Product Type:
        • Cryoprotectant Agents
          • Glycerol
          • Dimethyl Sulfoxide (DMSO)
          • Others
        • Equipment
          • Incubators
          • Liquid Nitrogen Supply Tanks
          • Freezers
          • Others
      • By Application:
        • Stem Cells
        • Oocytes and Embryos
        • Sperm, Semen, and Testicular Tissue
        • Hepatocytes
        • Others
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Academic and Research Institutes
        • Biobank
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Cryoprotectant Agents
          • Glycerol
          • Dimethyl Sulfoxide (DMSO)
          • Others
        • Equipment
          • Incubators
          • Liquid Nitrogen Supply Tanks
          • Freezers
          • Others
      • By Application:
        • Stem Cells
        • Oocytes and Embryos
        • Sperm, Semen, and Testicular Tissue
        • Hepatocytes
        • Others
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Academic and Research Institutes
        • Biobank
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Cryoprotectant Agents
          • Glycerol
          • Dimethyl Sulfoxide (DMSO)
          • Others
        • Equipment
          • Incubators
          • Liquid Nitrogen Supply Tanks
          • Freezers
          • Others
      • By Application:
        • Stem Cells
        • Oocytes and Embryos
        • Sperm, Semen, and Testicular Tissue
        • Hepatocytes
        • Others
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Academic and Research Institutes
        • Biobank
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Cryoprotectant Agents
          • Glycerol
          • Dimethyl Sulfoxide (DMSO)
          • Others
        • Equipment
          • Incubators
          • Liquid Nitrogen Supply Tanks
          • Freezers
          • Others
      • By Application:
        • Stem Cells
        • Oocytes and Embryos
        • Sperm, Semen, and Testicular Tissue
        • Hepatocytes
        • Others
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Academic and Research Institutes
        • Biobank
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Cryoprotectant Agents
          • Glycerol
          • Dimethyl Sulfoxide (DMSO)
          • Others
        • Equipment
          • Incubators
          • Liquid Nitrogen Supply Tanks
          • Freezers
          • Others
      • By Application:
        • Stem Cells
        • Oocytes and Embryos
        • Sperm, Semen, and Testicular Tissue
        • Hepatocytes
        • Others
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Academic and Research Institutes
        • Biobank
        • Others
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Cryoprotectant Agents
          • Glycerol
          • Dimethyl Sulfoxide (DMSO)
          • Others
        • Equipment
          • Incubators
          • Liquid Nitrogen Supply Tanks
          • Freezers
          • Others
      • By Application:
        • Stem Cells
        • Oocytes and Embryos
        • Sperm, Semen, and Testicular Tissue
        • Hepatocytes
        • Others
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Academic and Research Institutes
        • Biobank
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • General Electric Company*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • AMS Biotechnology (Europe) Limited
  • Miltenyi Biotec GmbH
  • BioLifeSolutions Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • PromoCell GmbH
  • Corning Incorporated
  • Cooper Companies, Inc.
  • Planer PLC

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Collaboration and Acquisitions
    • New Product Launches
    • Regulatory Scenario
    • Merger and Acquisition Scenario
    • PEST Analysis
    • PORTER’S Analysis
  4. Global Cell Cryopreservation Market, By Product Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Cryoprotectant Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
        • Glycerol
        • Dimethyl Sulfoxide (DMSO)
        • Others
    • Equipment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
        • Incubators
        • Liquid Nitrogen Supply Tanks
        • Freezers
        • Others
  5. Global Cell Cryopreservation Market, By Application, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Stem Cells
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Oocytes and Embryos
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Sperm, Semen, and Testicular Tissue
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Hepatocytes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Cell Cryopreservation Market, By End User, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Pharmaceutical and Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Biobank
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Cell Cryopreservation Market , By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • General Electric Company
        •  Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific Inc.
        •  Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck KGaA
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AMS Biotechnology (Europe) Limited
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Miltenyi Biotec GmbH
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Corning Incorporated
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BioLifeSolutions Inc.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • HiMedia Laboratories Pvt. Ltd.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • PromoCell GmbH
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Cooper Companies, Inc.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Planer PLC
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 25 figures on "Cell Cryopreservation Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.